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Abstract Among other Lyssaviruses, Daubenton’s and
pond-bat-related European bat lyssavirus type 2 (EBLV-2)
can cause human rabies. To investigate the diversity and
evolutionary trends of EBLV-2, complete genome se-
quences of two Finnish isolates were analysed. One
originated from a human case in 1985, and the other
originated from a bat in 2009. The overall nucleotide and
deduced amino acid sequence identity of the two Finnish
isolates were high, as well as the similarity to fully se-
quenced EBLV-2 strains originating from the UK and the
Netherlands. In phylogenetic analysis, the EBLV-2 strains
formed a monophyletic group that was separate from other
bat-type lyssaviruses, with significant support. EBLV-2
shared the most recent common ancestry with Bokeloh bat
lyssavirus (BBLV) and Khujan virus (KHUV). EBLV-2
showed limited diversity compared to RABV and appears
to be well adapted to its host bat species. The slow tempo
of viral evolution was evident in the estimations of diver-
gence times for EBLV-2: the current diversity was esti-
mated to have built up during the last 2000 years, and
EBLV-2 diverged from KHUV about 8000 years ago. In a
phylogenetic tree of partial N gene sequences, the Finnish
EBLV-2 strains clustered with strains from Central Europe,
supporting the hypothesis that EBLV-2 circulating in
Finland might have a Central European origin. The Finnish
EBLV-2 strains and a Swiss strain were estimated to have
diverged from other EBLV-2 strains during the last
1000 years, and the two Finnish strains appear to have
evolved from a common ancestor during the last 200 years.
Introduction
Rabies is a fatal and incurable zoonotic disease caused by
RNA viruses belonging to the genus Lyssavirus within the
family Rhabdoviridae. The negative-sense lyssavirus gen-
ome encodes five proteins: nucleoprotein (N), phospho-
protein (P), matrix protein (M), glycoprotein (G) and RNA
polymerase (L) in the order 30-N-P-M-G-L-50. Phyloge-
netic analysis and the virus-host relationship suggest that
all 15 currently known lyssaviruses probably originated in
bats and can be divided into phylogroups. Phylogroup I
comprises the classical rabies virus (RABV) and the ma-
jority of bat lyssaviruses, whereas Lagos bat virus (LBV)
and Shimoni bat virus (SHIBV) form phylogroup II [1, 2].
West Caucasian bat virus (WCBV), Ikoma lyssavirus
(IKOV) and Lleida bat lyssavirus (LLEBV) may be rep-
resentatives of a possible new phylogroups [3–5].
The first record of a rabid bat in Europe occurred in
Germany in 1954 [6], but only with the advent of antigenic
typing and molecular tools could European bat lyssavirus
(EBLV) be characterised and distinguished from classical
RABV and other lyssaviruses [7, 8]. After the death of a
Swiss bat biologist in Finland in 1985 and subsequent
characterisation of the causative agent, it became evident
that bat rabies in Europe at the time was caused by two
different lyssaviruses, EBLV-1 and 2 [7, 9]. Both of these
viruses are genetically and antigenically related to RABV
but are significantly different from each other. Early
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genomic sequencing also indicated that two distinct genetic
lineages (a and b) of EBLVs have evolved, which appeared
to cluster geographically [10, 11].
During 1977–2013, 1064 rabies cases were reported in
11 of the 45 known indigenous bat species in 16 European
countries [12]. Although numerous human contacts with
European bats, primarily from handling sick or injured
animals, have been reported [13], only a few EBLV-in-
duced human casualties have been conclusively demon-
strated: in Voroshilovgrad, Ukraine (1977), in Belgorod,
Russia (1985), in Finland (1985) and in the UK in Scotland
(2002) [9, 14–17]. The Russian case was genetically typed
as being EBLV-1a, while the Ukrainian case is only as-
sumed to be EBLV-1 from antigenic profiling [15, 18]. The
virus variants responsible for human rabies cases in the UK
and Finland were typed as being EBLV-2a and b, respec-
tively [17]. Subsequently, two other human rabies cases
after a bat bite have been described in Ukraine [15].
However, these cases were diagnosed clinically and on the
basis of anamnesis, and no virological or pathological re-
sults are available.
EBLV-2 is known to associate with two closely related
Myotis bat species, Daubenton’s (Myotis daubentonii) and
pond bats (M. dascyneme). The first isolation of EBLV-2
from a bat was carried out in 1987 from a pond bat in the
Netherlands [19]. Elsewhere in Europe, EBLV-2 has been
isolated sporadically from Daubenton’s bats in Switzerland
[20], the UK [21, 22], Germany [23] and Finland [24]. In
1986, EBLV was detected in one Danish Daubenton’s bat
and in one pond bat, but the causative strains were not
analysed further. EBLV-2 was, however, demonstrated
later in 2013 in mouth swabs from two Danish Daubenton’s
bats using a molecular diagnostic strategy [25]. The strains
from the UK and from the Netherlands appear to be closely
related, as are the strains from Germany and those isolated
from Switzerland [26]. The Finnish EBLV-2 strains and a
strain from Switzerland have been suggested to form a
lineage designated as EBLV-2b, with rest of the isolates
forming the lineage EBLV-2a [10, 11]. EBLV-2 strains
appear to form clusters according to the geographical area
and year of isolation.
Evolutionary studies on lyssaviruses have tended to fo-
cus on the N protein, a conserved structural protein, and the
G protein, which contains domains responsible for host-cell
receptor recognition and membrane fusion, and which is
the major target for the host neutralizing antibody response
[1]. Previously, comprehensive evolutionary analysis has
demonstrated that EBLV-1 and EBLV-2 have differing
population structures and dispersal patterns. Molecular-
clock estimates have suggested that the current linage of
EBLV-1 arose some 500 to 750 years ago [27]. Little is
known about the forces shaping the evolution of EBLV-2,
and only three strains of EBLV-2 have previously been
fully sequenced (EU293114, EF157977 and KF155004).
Finland has been free of rabies in terrestrial mammals
since 1991. Nevertheless, rabies can remain a residual risk
to public health due to the natural circulation of EBLV-2
[24, 28]. Here, we describe the phylogenetic analysis of
two Finnish EBLV-2 strains, the first isolated from a hu-
man in 1985 and the second from a diseased bat in 2009.
Using these isolates as a calibrator, this study provides an
estimate of the EBLV-2 molecular clock. Increased infor-
mation on the genome sequences of lyssaviruses is fun-
damental to understanding their epidemiology and
evolution, and to demonstrating the importance of con-
tinuous surveillance and molecular characterization of
lyssaviruses circulating in animal populations.
Materials and methods
Virus isolation in MNA cells and in suckling mice
Ethical approval and permission
The National Animal Experiment Board of the County
Administrative Board of Southern Finland approved the
diagnostic mouse inoculation test (permission number
ESLH-2008-06899/Ym-23), which followed Finnish leg-
islation, namely, the Finnish Act on the Use of Animals for
Experimental Purposes (62/2006).
Human bat virus isolate FI-85 [9, 16] used in this study
was the first archived newborn-mouse passage and had
been kept at -70 C since 1986. Virus isolation of the bat
virus isolate FI-09 [24] was attempted in MNA cell culture
(mouse neuroblast cells, Neuro-2a [ATCC CCL-131TM]),
with three additional passages according to a procedure
described in the OIE manual [29]. The bat brain suspension
was subsequently inoculated into suckling mice. Eight
newborn mice (ScaNmri) at 2 days old were intracerebrally
infected with 20 ll of the suspension in a BSL-3 labora-
tory. When the mice started to develop signs of en-
cephalitis, they were euthanized and the brains were
collected and examined using a fluorescence antibody test
(FAT) for the presence of lyssavirus as described earlier by
Jakava-Viljanen et al. [24].
RNA extraction, primer design and RT-PCR
RNA was extracted from the brain suspensions of the mice
using a QIAamp Viral RNA Mini Kit (QIAGEN, Germany,
Hilden) according to the manufacturer’s instructions. Pri-
mers (Table 1) were designed with the program PCR Suite
[30] and modified afterwards, if needed. A OneStep RT-
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PCR Kit (QIAGEN, Hilden, Germany) was used to amplify
34 overlapping fragments. The following thermal profile
was used: a single cycle of reverse transcription for 30 min
at 50 C, 15 min at 94 C for reverse transcriptase inacti-
vation and DNA polymerase activation, followed by 30
amplification cycles of 1 min at 94 C, 1 min at 50 C and
1 min at 72 C. After agarose gel electrophoresis, the
bands were cut from the gel and DNA was extracted using
a QIAquick Gel Extraction Kit (QIAGEN, Hilden,
Germany).
Sequencing and sequence analysis
PCR products were sequenced using an ABI 3100 Avant
Genetic Analyser (Applied Biosystems) with the primers
used in the PCR and a Big Dye Terminator v3.1 Cycle
Sequencing Kit (Applied Biosystems). Before sequencing,
the reaction products were purified using a DyeEx 2.0 Spin
Kit (QIAGEN, Hilden Germany). The sequences were
analysed with Sequencing Analysis software version 6.0
(Applied Biosystems).
Phylogenetic analysis
The newly determined sequences (GenBank accession
numbers JX129232 and JX129233) were aligned with other
published full-length lyssavirus sequences from bat-type
isolates obtained from GenBank to evaluate the genetic
Table 1 Primers used in the RT-PCR and sequencing. The position
numbering is according to the EBLV-2 isolate RV1333 (EF157977)
Primer Sequence (5’-3’) Position
1f acg ctt aac gac aaa acc ag 1 - 20
1r tag ctc tcc caa tcg tca gg 326 - 345
2f cgc tag gtt gga tcc tga tg 256 - 275
2r ggc gca cat ctt gtg agt ag 636 - 655
3f cca acg tag ctg aca gaa tgg 558 - 578
3r aca tct cgt gag gtg cac ag 1066 - 1085
4f cgg gag tta cat ggg tca ag 1015 - 1034
4r gtc tgg cct gat gat tcg ag 1354 - 1373
5f cag gat cat ggt caa tgg 1291 - 1308
5r tcc caa cac cct caa ggt ag 1812 -1831
6f aag aag aag gaa gcg atg agg 1745 - 1765
6r tgc gct att tct gct tca ac 2116 - 2135
7f acc tgc gct gga atg gtc 2070 - 2087
7r ggg agc cat agg tca tca tc 2591 - 2610
8f agt gag agg ttg cag gga tg 2530 - 2549
8r act ctg ccc att gaa aca cc 2869 - 2888
9f ttc cag agg gaa tga act gg 2826 - 2845
9r ggt gtt cag tcg ggt gtt tc 3245 - 3264
10f ctt tta tga gca ata gaa caa aac c 3186 - 3210
10r atg tcg gat cac ctg cag tc 3688 - 3704
11f aac tac cac gtt caa gag aaa gc 3619 - 3641
11r ttt gcc tca tcg tga ttt tg 4115 - 4134
12f tga aac tgt gtg gaa tct ctg g 4059 - 4080
12r atg ctg ttg aag cat tgc ag 4518 - 4537
13f tcc tca tca caa tgg agt ctt c 4441 - 4462
13r ccc act ttg gga agt gac ag 4830 - 4849
14f aaa gag agc caa acc caa cc 4787 - 4805
14r att gca tcc tct ccc act tg 5154 - 5171
15f acc ggt aca cag ggt ctt gc 5076 - 5095
15r gca tct atc tcc ggt tcg ac 5458 - 5477
16f aga tga ttg atc ccc tgg ag 5414 - 5433
16r gag gca ctt tcg act tct gg 5747 - 5766
17f cgc aca atc cat gat gtc tc 5697 - 5716
17r gaa tca gga ggg agt tga acc 6173 - 6193
18f tct cag agt gcc aac tgt ctg 6106 - 6126
18r gtt cct tca agc tgg ctc ac 6415 - 6434
19f tta gtg cag agg gct gaa gg 6340 - 6359
19r tat ggg atc aaa ggg tgg tc 6709 - 6728
20f ctg gct aaa cgg atc ctc ag 6634 - 6653
20r aag aat tcc ctg ggg ttg ac 6964 - 6983
21f ccg tcc cca gtg aga aag tc 6917 - 6936
21r gac ctt gtc ccg tga ctc tg 7209 - 7228
22f ttg gcg aac tac atc tta ccc 7129 - 7149
22r tga gtc cct ctt ggg tca ac 7641 - 7660
23f agc aca ggg aga caa cca ag 7590 - 7609
23r gtg aaa tac cgc ctg gac tg 7979 - 7998
24f gtc gca cag cat tca caa tc 7924 - 7943
24r agc aga atg gtt gga ctt gc 8332 - 8351
Table 1 continued
Primer Sequence (5’-3’) Position
25f ccg gac ttg ggt gat aga ag 8254 - 8273
25r aaa ttg ccg tcg aat tgt tc 8567 - 8586
26f gct cat cct tcc tcg gaa tac 8513 - 8533
26r gat ttg agt ccc tgg caa tg 9021 - 9040
27f cca acg tcc atg ttg tca ag 8966 - 8985
27r aga cat ccg gga aca tga ag 9417 - 9436
28f caa gtg cat ccg acc gat ag 9369 - 9388
28r cag atc gaa gtg agg gtt cc 9831 - 9850
29f tgt tga ggc tag aca atc atc c 9788 - 9809
29r taa ggt gtc ttc ccc gtg ac 10151 - 10167
30f atc cga ctc agg cag ttg ag 10105 - 10124
30r gag gcc atg agg tca ttc ac 10606 - 10625
31f tgg aat ctc cag aac tgt gc 10539 - 10558
31r tgg cct tgt agt ctg ggt tc 10923 - 10942
32f ctc tcg atc aat ggt cca ctc 10867 - 10887
32r tta gcc aag gtc cct ctt tg 11287 - 11306
33f tga agt cga gtc att cct agt cc 11238 - 11260
33r gct act acc ggc aag tcg ag 11672 - 11691
34f aag caa gtc ata cga gga ag 11533 - 11552
34r acg ctt aac aaa aaa aac ata g 11909 - 11930
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diversity of EBLV-2 strains and their relationship to other
bat-associated genotypes. Amino acid sequences were de-
duced using the ‘‘translate’’ function of the program MEGA
v.5.1 [31]. Phylogenetic trees of full-length genomes and
partial N coding sequences were calculated using the
maximum-likelihood approach in the program MEGA with
1000 bootstrap replicates. The pairwise sequence identities
were calculated using CLUSTAL W2 (http://www.ebi.ac.
uk/Tools/msa/clustalw2/), with default settings.
Rate of evolution and time of divergence
The program BEAST [32] was used to estimate the sub-
stitution rate of EBLV-2 and time of divergence from the
phylogenetically closest lyssaviruses. The data set used for
estimating the rate of evolution was based on the partial N
coding sequences (400 bp) of EBLV-2 strains isolated
from the years 1986 to 2012. The HKY model of nu-
cleotide substitution was used [33] with both strict and
relaxed lognormal clock models. Convergence of pa-
rameters was assessed using TRACER [32], and each run
was continued until the effective sampling size of all pa-
rameters was greater than 200.
Results
Isolation of the EBLV-2 FI-09 strain in MNA cells
and suckling mice
Inoculation of the bat sample into MNA cells revealed the
presence of virus in only a limited number of cells after
3 days of incubation, and after the three subsequent pas-
sages, the tissue culture infection test was negative. When
the cell culture isolation was unsuccessful, the brain sus-
pension of the bat was inoculated into suckling mice. The
mice began to develop signs of encephalitis on day 12 p.i.
By day 17 p.i., all eight mice were euthanized. The pres-
ence of the virus in all of the brain samples was confirmed
by FAT.
EBLV-2 genome, genomic distance
and phylogenomic pattern
The complete lengths of the FI-85 and FI-09 genomes were
11,928 and 11,927 nucleotides, respectively (GenBank
accession numbers JX129233-JX129232). Twenty nu-
cleotides at the 5’ end and 22 nucleotides at the 3’ end of
the genomes were primer-derived and were excluded from
all phylogenetic analyses.
The general genome organization was typical for
lyssaviruses, consisting of five structural genes, N, P, M, G
and L, and non-coding regions between them and at both
ends of the genome. The lengths of the genes and the
number of deduced amino acids (in parentheses) were 1356
(451 aa), 894 (297 aa), 609 (202 aa), 1575 (524 aa) and
6384 (2127 aa), respectively. The long untranslated region
between the G and L genes was the only area that varied in
length between the two Finnish EBLV-2 strains, being
510 bp in FI-85 and 509 bp in FI-09. The corresponding
lengths for other completely sequenced EBLV-2 strains
were 511 bp for EU293114 and 512 bp for KF155004 and
EF157977.
The nucleotide sequence identity between the FI-85 and
FI-09 strains was 99.6 %. There were four amino acid
differences between the two Finnish strains: N gene aa 106
(N[\S), G gene aa 158 (V[\A), L gene aa 154 (R[\K)
and aa 1656 (G[\D). The N, P, M, G and L genes of the
FI-85 and FI-09 strains shared 98–99 %, 98 %, 99–100 %,
97–99 % and 99 % amino acid sequence identity, respec-
tively, with the previously published EBLV-2 strains. The
similarity plot in Figure 1 displays the similarities along
the genome. The non-coding regions are highly divergent,
yet rather similar for all EBLV-2 strains.
Phylogenetic analysis and evolutionary trends
A phylogenetic tree was constructed based on the genome
sequences of the two new EBLV-2 isolates and the full-
length genome sequences of bat-related lyssavirus obtained
from GenBank (Fig. 2). The analysis revealed that all five
EBLV-2 strains are monophyletic. The phylogenetic tree
also demonstrated that EBLV-2 strains share the most re-
cent common ancestry with BBLV and KHUV, and more
distant ancestry with ARAV, RABV and ABLV (albeit
with low bootstrap support). A second major cluster of
lyssaviruses consists of IRKV, DUVV and EBLV-1. The
clearly most divergent group is formed by SHIV, LBV and
WCBV.
In order to include more EBLV-2 strains, we constructed
a second phylogenetic tree (Fig. 3) based on partial N gene
sequences (400 nt), which are much more abundant in the
GenBank database. EBLV-2 strains were also mono-
phyletic in this region. Some discrepancies were observed
between the two trees, especially in the composition of the
major clusters, which were not reproduced in the phy-
logeny based on partial N gene sequences.
The substitution rate of European bat lyssavirus-2 was
estimated using the two Finnish strains isolated 24 years
apart as a calibrator. The overall rate was 7.67 9 10-5
substitutions per site per year. The current diversity of
EBLV-2 was estimated to have appeared during the last
2000 years. However, EBLV-2 and other phylogroup I
viruses were estimated to have already diverged from other
lyssaviruses at about 8000 years ago (Fig. 4). The diver-
gence of Finnish EBLV-2 strains and a strain from
1492 J.-V. Miia et al.
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Fig. 2 Phylogenetic tree of
lyssaviruses estimated using
complete coding sequences. The
phylogenetic tree was calculated
using the maximum-likelihood
approach in the program MEGA
[30] with 1000 bootstrap
replicates
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Switzerland from other EBLV-2 strains has occurred dur-
ing the last 1000 years. The two Finnish strains have
evolved from a common ancestor during the last 200 years.
Discussion
Sequencing, phylogenetic analysis and evolutionary ana-
lysis of Finnish EBLV-2 strains isolated from a human case
in 1985 and from a bat in 2009 were described. It was
shown that the EBLV-2 isolates share high nucleotide and
amino acid sequence identity, regardless of the year and
origin of isolation, but they also cluster according to the
host species and the geographical place of isolation.
The closest relatives to EBLV-2 (Bokeloh and KHUV)
are lyssavirus strains from Myotis bats from Germany and
Tajikistan. An interesting case is ARAV (originating from
Kyrgystan), which has an uncertain position in the phylo-
genetic analysis. The possibility of recombination of rabies
viruses has been demonstrated in earlier studies [34–36].
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Fig. 3 Phylogenetic tree based on partial N gene (400 nt) sequences. The phylogenetic tree was calculated using the maximum-likelihood
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Lleida bat lyssavirus, detected in a bent-winged bat (M.
schreibersii) in Spain in 2011 [5], is the most unique lys-
savirus in Europe based on the N gene, although the whole
genome sequence is not available. WCBLV has also been
detected in M. schreibersii, and antibodies against WCBV
have been detected in Africa in Miniopterus bats [37]. The
tree topology was somewhat different in the phylogeny
based on either the complete coding sequences or the
commonly used partial N sequences, and it should be ap-
preciated that for a detailed analysis of evolutionary his-
tory, complete genomes should be used. The limitation of
this study, as in other studies, is the amount of data
available for comparison.
The nucleotide sequence identity (deduced amino acid
sequence identity) between FI-85 and FI-09 was 99.6 %
(99.8 %). The N, M and L proteins were similar in
structure and length between members of different lyssa-
virus species and strains, whereas the lengths of the P and
cytoplasmic regions of the G protein were variable [38–
40]. No differences in structure were seen in the Finnish
EBLV-2 isolates in comparison to other EBLV-2 complete
genomes [40–42]. The similarity plot in Figure 1 further
demonstrates the similarities along the genomes of differ-
ent lyssaviruses. Interestingly, the non-coding regions,
which are highly divergent in other lyssaviruses, were
rather similar for all EBLV-2 strains.
Based on this study, we estimate that the Finnish EBLV-
2 strains and one Swiss strain from among the other EBLV-
2 strains have evolved from a common ancestor during the
last 1000 years. Earlier, the Finnish strains and the strain
from Switzerland were suggested to form the lineage
EBLV-2b, whereas the rest of the isolates form the lineage
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EBLV-2 JQ796812  M. daubentonii GB 2008
EBLV-2 U89479 M. daubentonii CH 1993
EBLV-2 JQ796808 M. daubentonii GB 2003
BBLV JF311903 M. naereri DE 2010
2548
114
1166
442
8155
88
953
173
201
1108
11140
442
713
251
190
578
1394
143
82
111
150
452
759
2047
244
Rate of evolution: 7.67 x 10-5
Fig. 4 Phylogenetic tree of EBLV-2 based on partial N gene (400 nt)
sequences with a molecular-clock estimate. The program BEAST [32]
was used to estimate the substitution rate of EBLV-2 and time of
divergence from the phylogenetically closest lyssavirus. The HKY
model of nucleotide substitution was used [33] with both strict and
relaxed lognormal clock models. Convergence of parameters was
assessed using TRACER [31], and each run was continued until the
effective sampling size of all parameters was greater than 200
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EBLV-2a [10, 11, 20, 27]. In our study, there was a divi-
sion into subgroups EBLV-2a and EBLV-2b when full
genomes were compared (Fig. 2), but when more strains
were compared using shorter, 400-bp N gene sequences,
we could not confirm the suggested division into subgroups
(Fig. 3). In our comparison, the Finnish strains and the
strain from Switzerland also clustered together based on N
gene analysis. Interpretation of the molecular epidemiology
of the strains is further complicated by the history of the
Swiss bat biologist who died in Finland in 1985 of EBLV-2
infection (JX129233), who had been bitten 51 days before
the onset of clinical signs by a Daubenton’s bat that was
abnormal. The bat was freed before the patient developed
symptoms and was not available for rabies analysis [16].
However, it is possible that the bat originated from Central
Europe, possibly from Switzerland, even though the ex-
posure took place in Finland.
The molecular clock estimates suggest that the current
linage of EBLV-2 arose some 2000 years ago and that the
most recent common ancestor (MRCA) occurred around
8000 years ago. In earlier molecular clock studies, Tao et al.
[43] estimated based on G gene analysis that the time to the
most common ancestor (TMRCA) of all lyssaviruses was
approximately 5030 years. The West Caucasian bat virus
divided first, and then phylogroup I and phylogroup II di-
vided about 4000 years ago [43]. Davis et al. [27] estimated
that the MRCA of EBLV-1 existed around 500 to 750 years
ago based on G and N sequences, or 70 to 300 years ago,
depending on the substitution rate [44]. The molecular
clock estimates cannot be used to precisely describe events
that occurred thousands, or even tens of thousands of years
ago, since sequence data only exist from the last few dec-
ades. The overall rate of evolution appears somewhat
slower for the bat-type lyssaviruses than for RABV. This is
in line with bats being considered the true reservoir of
lyssaviruses. The overall evolution rate for EBLV-2 in our
study was 7.67 9 10-5 substitutions per site per year. For
RABV, it has been suggested to be 1.56–1.78 9 10-4 [45],
and 1 9 10-3 to 5.5 9 10-4 [7, 43, 46, 47], and for EBLV-
1, 5–6 9 10-5 to 5–6 9 10-4 [27].
Behavioural and ecological traits of bats, such as
hibernation, migration and coloniality, might influence
viral evolution. Some rabies virus lineages evolve up to 22
times faster than others, depending on the reservoir host
[48, 49]. Virus lineages in bat species in the temperate
climate zone were found to have four times slower rates of
evolution than lineages in bats from tropical or subtropical
climates, and viral evolution was faster in bats that remain
active year-round in comparison to bats that hibernate. This
could be a major factor in a cold climate region such in
Finland. Viral evolutionary rates were similarly uncon-
strained by host evolutionary relatedness such that
lyssaviruses associated with closely related bat species or
subspecies often had dissimilar evolutionary rates. Stre-
icker et al. [48] demonstrated that the local host environ-
ment determines the evolutionary rates of lyssaviruses.
Daubenton’s bats are facultatively seasonal migrants cov-
ering middle-range distances of 100–150 km [50], which
supports the clustering of EBLV-2 according to the geo-
graphical place of isolation. In Finland, antibodies to
EBLVs have only been detected in a restricted geo-
graphical area close to the location where the EBLV-2-
positive bat was found in 2009 [28]. In a study of
Daubenton’s bats from Finland, the UK, Switzerland and
Spain, no population structuring was observed [51].
Daubenton’s bats migrate between the UK and the main-
land, and the genetic structure of Daubenton’s bats is
relatively homogeneous in western parts of Europe [52].
This could explain the relatedness within the proposed
lineage 2a. As the migration pattern of Daubenton’s bats
does not support the finding that the Finnish EBLV-2
Daubenton’s bat strain is closely related to the EBLV-2
strain from Switzerland, one can speculate whether there
could have been contact between indigenous Finnish bats
and the bats that were freed in Finland and whose origin is
unknown [9, 16].
Increased information on the complete genome se-
quences of lyssaviruses is fundamental to understanding
their epidemiology and evolution and demonstrates the
importance of continuous monitoring and molecular char-
acterization of lyssaviruses circulating in human and ani-
mal populations.
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